2025 annual financial data
Monopar Therapeutics 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -16,704,415 USD and net income was -13,716,894 USD.
Operating cash flow was -12,201,291 USD.
Get free Monopar Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -16,704,415 USD
- Net income
- -13,716,894 USD
- Operating cash flow
- -12,201,291 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Monopar Therapeutics financial years